BAMBI is a novel HIF1-dependent modulator of TGFβ-mediated disruption of cell polarity during hypoxia |
|
Author: | Raykhel, Irina1; Moafi, Fazeh1; Myllymäki, Satu M.1; |
Organizations: |
1Oulu Center for Cell-Matrix Research, Biocenter Oulu, Faculty of Biochemistry and Molecular Medicine, University of Oulu 2Department of Surgery (Section of Research), University of Chicago |
Format: | article |
Version: | published version |
Access: | open |
Online Access: | PDF Full Text (PDF, 10.5 MB) |
Persistent link: | http://urn.fi/urn:nbn:fi-fe201902084425 |
Language: | English |
Published: |
Company of Biologists,
2018
|
Publish Date: | 2019-02-08 |
Description: |
AbstractHypoxia and loss of cell polarity are common features of malignant carcinomas. Hypoxia-inducible factor 1 (HIF1) is the major regulator of cellular hypoxia response and mediates the activation of ∼300 genes. Increased HIF1 signaling is known to be associated with epithelial–mesenchymal transformation. Here, we report that hypoxia disrupts polarized epithelial morphogenesis of MDCK cells in a HIF1α-dependent manner by modulating the transforming growth factor-β (TGFβ) signaling pathway. Analysis of potential HIF1 targets in the TGFβ pathway identified the bone morphogenetic protein and activin membrane-bound inhibitor (BAMBI), a transmembrane glycoprotein related to the type I receptors of the TGFβ family, whose expression was essentially lost in HIF1-depleted cells. Similar to what was observed in HIF1-deficient cells, BAMBI-depleted cells failed to efficiently activate TGFβ signaling and retained epithelial polarity during hypoxia. Taken together, we show that hypoxic conditions promote TGFβ signaling in a HIF1-dependent manner and BAMBI is identified in this pathway as a novel HIF1-regulated gene that contributes to hypoxia-induced loss of epithelial polarity. see all
|
Series: |
Journal of cell science |
ISSN: | 0021-9533 |
ISSN-E: | 1477-9137 |
ISSN-L: | 0021-9533 |
Volume: | 131 |
Issue: | 10 |
Article number: | jcs210906 |
DOI: | 10.1242/jcs.210906 |
OADOI: | https://oadoi.org/10.1242/jcs.210906 |
Type of Publication: |
A1 Journal article – refereed |
Field of Science: |
1182 Biochemistry, cell and molecular biology |
Subjects: | |
Funding: |
This work was supported Academy of Finland Research Council for Health grants [114344 (J.M.), 296498 (J.M.), 135560 (A.M.), 263770 (A.M.)] and Academy of Finland Center of Excellence 2012-2017 grant (251314 to J.M., A.M.), Sigrid Juséliuksen Säätiö (J.M.), Jane ja Aatos Erkon Säätiö (J.M.) and FibroGen Inc. (J.M.). |
Academy of Finland Grant Number: |
114344 296498 135560 263770 251314 |
Detailed Information: |
114344 (Academy of Finland Funding decision) 296498 (Academy of Finland Funding decision) 135560 (Academy of Finland Funding decision) 263770 (Academy of Finland Funding decision) 251314 (Academy of Finland Funding decision) |
Dataset Reference: |
Supplementary information: |
http://jcs.biologists.org/lookup/doi/10.1242/jcs.210906.supplemental |
|
Copyright information: |
© 2018. Published by The Company of Biologists Ltd. |